logo
Sign InSign Up

JOHNSON & JOHNSON (JNJ)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for JNJ, sign up here.

Income Statement

Revenue

$85.2bn

Gross Profit

$58.6bn

Earning before Tax

$36.9bn

Net Income

$35.2bn

Net Income Common Shareholders

$35.2bn

EPS

13.88

Balance Sheet

Cash

$21.9bn

Debt

$29.3bn

Assets

$167.6bn

Liabilities

$98.8bn

Equity

$68.8bn

Enterprise Value

$387.5bn

Cash Flow Statement

Net Cash from Operations

$22.8bn

Net Cash from Investing

$878.0m

Net Cash from Financing

$-15.8bn

Net Cash Flow

$7.7bn

Free Cash Flow

$18.2bn

Free Cash Flow per Share

$7.20

Metrics

Price to Equity

10.73

Price to Equity (Damodaran)

11.29

Price to Book

5.49

Net Margin

0.41

Return on Equity

0.49

Return on Sales

0.44

Get immediate access to 5-years of reference grade data for JNJ for free.

Sign up

Company Profile

Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company''s Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Company Info

Industry

Drug Manufacturers - General

Employees

Address

One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States

Phone

732 524 0400

Last Updated

2024-02-19

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy